Safe and effective opioid use in pain management: A clinician’s prescribing perspective: pharmacists
Pharmacists in community-based practice.
Universal program number: 0401-0000-17-057-L01-P
CE Broker tracking number: 20-573857
Activity type: Knowledged-based
Date: Wednesday, June 28 from 8:00 p.m. - 9:00 p.m. EDT
It goes without saying that we are still in the middle of a crisis with continued increases in both addiction and overdose deaths from both prescription and street-obtained opioids. Both federal and state governments have enacted (or suggested) a variety of actions in an attempt to stem the tide. This session will review a number of consensus-based measures that healthcare providers/prescribers use to assess patients for treatment with opioids, including risk/benefit analysis, establishing tangible treatment goals, patient-provider agreements, informed consent, monitoring patients for efficacy, side effects and safety, including aberrant behaviors associated with abuse risk. Within this framework, there will be emphasis on select points where communication between prescribing clinicians and pharmacists is paramount to ensure the best and safest outcomes for patients and the community.
- Discuss how a prescribing clinician accurately assesses patients with pain for consideration of an opioid trial.
- Describe how realistic goals for pain management and restoration of function are conveyed to patients.
- Review the step-wise approach for initiating opioids in patients with acute pain.
- Discuss logistics surrounding faxed, e-scribed, future-dated and blank signed prescriptions.
- Counsel patients and caregivers about use, misuse, abuse, diversion and overdose.
- List options by which pharmacists and prescribers can work together to ensure patient safety.
To obtain credit:
Attendees must participate in the entire program by viewing the presentation on a smartphone, tablet or desktop or laptop computer, listening to the presenters with audio from the device or a linked telephone connection, responding to polling questions and submitting questions within the GotoWebinar platform. Following the presentation, attendees must return to the lesson within Drug Store News to attest to active participation and to select a participation code that will be displayed by the moderator during the on-screen presentation. An evaluation of the program is also required.
Please note, live CPE credit will not be awarded for participants who choose to dial in by phone without also viewing the presentation.
Official statements of credit are available online through CPE Monitor.
All claims for live CPE credit must be submitted no later than 30 days following live programs.
If you have a question, visit our Frequently Asked Questions page.
For questions concerning the GotoWebinar platform access visit www.gotowebinar.com
All other customer service questions should be directed to DRSNCE@lf1925.com.
Drug Store News is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This CPE activity is approved for pharmacists and is worth 1.0 contact hours (0.1 CEUs).
Jody Agins, MSN, RNP, FNP/GNP-BC, clinical services director, Agape Hospice and Palliative Care, Tucson, Arizona; founder and executive director of Collaborative Medical Provider Group (PLLC), Tucson, Arizona; primary care provider, Caremore Touch (Anthem)
Jody Agins and the DSN editorial and continuing education staff do not have any actual or potential conflicts of interest in relation to this lesson.
- 1.00 Pharmacist